Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ahmad, Zarzour"'
Autor:
Nagla A. Karim, Hai Bui, Peterson Pathrose, Sandra Starnes, Ninad Patil, Mahmoud Shehata, Ahmed Mostafa, MB Rao, Ahmad Zarzour, Marshall Anderson
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2014, Iss 8, Pp 139-144 (2014)
Externí odkaz:
https://doaj.org/article/ce80f869711e4bd4ad51a92235003ebe
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2014, Iss 8, Pp 121-128 (2014)
Externí odkaz:
https://doaj.org/article/0d341ed739704110867e5757f74f68cf
Publikováno v:
Current Geriatrics Reports. 8:315-321
The purpose of this review is to summarize the key literature of complications and adverse effects experienced by elderly men undergoing androgen deprivation therapy for prostate cancer, as well as evidence-based strategies to manage these complicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17165bcb1f18c99f4f840d4442b49cb6
https://doi.org/10.1007/s13670-019-00303-8
https://doi.org/10.1007/s13670-019-00303-8
Autor:
Ahmad Zarzour, Tomas Radivoyevitch, Karam Al-Issa, Hetty E. Carraway, Betty K. Hamilton, Anjali S. Advani, Vera Adema, Bartlomiej P Przychodzen, Nour Abuhadra, Aziz Nazha, Mikkael A. Sekeres, Cassandra M. Hirsch, Jaroslaw P. Maciejewski, Aaron T. Gerds, Bhumika J. Patel, Sudipto Mukherjee
Publikováno v:
Leukemia. 31:2848-2850
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc7ebfe7c6cd2fd38889294b900d026
https://doi.org/10.1038/leu.2017.266
https://doi.org/10.1038/leu.2017.266
Autor:
Shahzad Raza, Rim Hasan, Belal Firwana, Ibrahim Yousef, Aref Al-Kali, Ahmad Zarzour, Mohamad Bassam Sonbol, Donald C. Doll, Maria Diab, Archana Garipalli, M. Hassan Murad
Publikováno v:
International Journal of Cancer. 138:1545-1553
Tyrosine kinase inhibitors (TKI) are the initial treatment for majority of newly diagnosed patients with chronic myelogenous leukemia (CML) in chronic phase (CP) and are associated with marked improvement in hematological, cytogenetic, molecular resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::257531ceff9e2a71b44a049074758c8e
https://doi.org/10.1002/ijc.29889
https://doi.org/10.1002/ijc.29889
Autor:
Ahmad Zarzour, El Mustapha Bahassi, So Ha Lee, Hashim M. Aljohani, Byung Sun Park, Robert F. Koncar
Publikováno v:
Oncotarget
Glioblastoma (GBM) is the most aggressive brain tumor in adults and remains incurable despite multimodal intensive treatment regimens. The majority of GBM tumors show a mutated or overexpressed EGFR, however, tumors treated with tyrosine kinase inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282f6bf2e35e9b0d6feaab355246084e
https://doi.org/10.18632/oncotarget.3981
https://doi.org/10.18632/oncotarget.3981
Autor:
Hai Bui, Ahmad Zarzour, Sandra L. Starnes, Nagla Abdel Karim, Peterson Pathrose, M.B Rao, Ninad M Patil, Ahmed Mostafa, Marshall W. Anderson, Mahmoud Shehata
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2014, Iss 8, Pp 139-144 (2014)
Clinical Medicine Insights: Oncology, Vol 8 (2014)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 8 (2014)
Clinical Medicine Insights. Oncology
Introduction Performance status (PS) is the only known clinical predictor of outcome in patients with advanced non-small-cell lung cancer (NSCLC), although pharmacogenomic markers may also correlate with outcome. The aim of our study was to correlate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e7dce4e8317201ad50ca551297a4ed
http://www.la-press.com/the-use-of-pharmacogenomics-for-selection-of-therapy-in-non-small-cell-article-a4548
http://www.la-press.com/the-use-of-pharmacogenomics-for-selection-of-therapy-in-non-small-cell-article-a4548
Autor:
Borko Jovanovic, Maha Hussain, Joshua J Meeks, Phillip L. Palmbos, Alicia K. Morgans, Sarki A. Abdulkadir, Ximing J. Yang, Scott A. Tomlins, Edward M. Schaeffer, Roohollah Sharifi, Ahmad Zarzour, David J. VanderWeele
Publikováno v:
Journal of Clinical Oncology. 37:TPS333-TPS333
e17517 Background: Although PCa incidence has stabilized/decreased in most age groups, the incidence of metastatic disease has increased among men 50-69 years-old. The incidence of fatal PCa has decreased for most age groups, it has remained unchange
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7379aa3ba4733d99c02885bda3b9df
https://doi.org/10.1200/jco.2019.37.7_suppl.tps333
https://doi.org/10.1200/jco.2019.37.7_suppl.tps333
Autor:
Tracy Y. Ansay, Ronald E. Warnick, El Mustapha Bahassi, Christopher M. McPherson, Ahmad Zarzour, Olivier Rixe, Mohamad Adham Salkeni
Publikováno v:
Journal of Neuro-Oncology. 115:27-35
Glioblastoma multiforme (GBM) is the most aggressive brain tumor in adults and remains incurable despite multimodal intensive treatment regimens including surgical resection, radiation and chemotherapy. EGFRvIII is a truncated extracellular mutant of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c43bbdf95083c9ad78ee84afec05727
https://doi.org/10.1007/s11060-013-1209-0
https://doi.org/10.1007/s11060-013-1209-0
Autor:
Ramon V. Tiu, Mohammad Morad, Mohamad Bassam Sonbol, Belal Firwana, Ahmad Zarzour, Vishal Rana
Publikováno v:
Therapeutic Advances in Hematology. 4:15-35
Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem-cell disorders, characterized phenotypically by the abnormal accumulation of mature-appearing myeloid cells. Polycythemia vera, essential thrombocythemia, primary myelofibrosis (also k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b44cb6cdde54d5e0db0851cdd44fbc8c
https://doi.org/10.1177/2040620712461047
https://doi.org/10.1177/2040620712461047